Commission Regulation (EC) No 542/2008 of 16 June 2008 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards cyfluthrin and lectin extracted from red kidney beans (Phaseolus vulgaris) (Text with EEA relevance) (c. 542)

ANNEX

A. In point 2.2.3 of Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed), the entry for ‘Cyfluthrin’ is replaced by the following:

2.2.3.

Pyrethroids

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘Cyfluthrin	Cyfluthrin (sum of isomers)	Bovine, caprine	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk	Further provisions in Directive 94/29/EC are to be observed’

B. In point 6 of Annex II (List of substances not subject to maximum residue limits), the following substance is inserted:

6.

Substances of vegetable origin

Pharmacologically active substance(s)	Animal species	Other provisions
‘Lectin extracted from red kidney beans (Phaseolus vulgaris)	Porcine	For oral use only’